Yang Chenlong, Zhao Jizong, Wu Bingquan, Zhong Haohao, Li Yan, Xu Yulun
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China.
J Mol Neurosci. 2017 Jan;61(1):8-15. doi: 10.1007/s12031-016-0836-2. Epub 2016 Sep 20.
Cerebral cavernous malformation (CCM) is a congenital vascular anomaly predominantly located within the central nervous system. Its familial forms (familial cerebral cavernous malformation (FCCM)), inherited in an autosomal dominant manner with incomplete penetrance, are attributed to mutations in CCM1/KRIT1, CCM2/MGC4607, and CCM3/PDCD10 genes. To date, little is known about the genetic alterations leading to FCCM in the Chinese population. We aimed to investigate the genetic defect of FCCM by DNA sequencing in Chinese families. This study enrolled five Chinese families with FCCM. All index cases underwent surgical treatment and were diagnosed with CCM by pathology; their relatives were diagnosed based on radiological and/or pathological evidence. Genomic DNA was extracted from peripheral blood and amplified using polymerase chain reaction (PCR) for DNA sequencing. The five families comprised a total of 21 affected individuals: 12 of these were symptomatic, and 9 were asymptomatic. Sequence analyses in the index patients disclosed three heterozygous loss-of-function mutations in the CCM1/KRIT1 gene in three families, respectively: a novel deletion mutation (c.1780delG; p.Ala594HisfsX67) in exon 16, a novel splice-site mutation (c.1412-1G>A) in the splice acceptor site in intron 13, and a previously described 4-bp deletion (c.1197_1200delCAAA; p.Gln401ThrfsX10) in exon 12. All of these mutations are predicted to cause a premature termination codon to generate a truncated Krev interaction trapped 1 (Krit1) protein. These mutations segregated in affected relatives. Our findings provided new CCM1 gene mutation profiles, which help to elucidate the pathogenesis of FCCM and will be of great significance in genetic counseling.
脑海绵状血管畸形(CCM)是一种主要位于中枢神经系统的先天性血管异常。其家族性形式(家族性脑海绵状血管畸形(FCCM))以常染色体显性方式遗传且具有不完全外显率,归因于CCM1/KRIT1、CCM2/MGC4607和CCM3/PDCD10基因的突变。迄今为止,对于导致中国人群FCCM的基因改变知之甚少。我们旨在通过对中国家族进行DNA测序来研究FCCM的基因缺陷。本研究纳入了五个患有FCCM的中国家族。所有索引病例均接受了手术治疗,并经病理诊断为CCM;其亲属根据影像学和/或病理证据进行诊断。从外周血中提取基因组DNA,并使用聚合酶链反应(PCR)进行扩增以进行DNA测序。这五个家族共有21名受影响个体:其中12名有症状,9名无症状。对索引患者的序列分析分别在三个家族的CCM1/KRIT1基因中发现了三个杂合功能丧失突变:外显子16中的一个新的缺失突变(c.1780delG;p.Ala594HisfsX67)、内含子13剪接受体位点中的一个新的剪接位点突变(c.1412-1G>A)以及外显子12中先前描述的4碱基缺失(c.1197_1200delCAAA;p.Gln401ThrfsX10)。所有这些突变预计都会导致过早终止密码子的产生,从而产生截短的Krev相互作用捕获蛋白1(Krit1)。这些突变在受影响的亲属中呈分离状态。我们的研究结果提供了新的CCM1基因突变谱,有助于阐明FCCM的发病机制,并且在遗传咨询中将具有重要意义。